Association of Sleep-Related Problems With CKD in the United States, 2005-2008

被引:59
作者
Plantinga, Laura [1 ]
Lee, Kathryn [2 ]
Inker, Lesley A. [3 ]
Saran, Rajiv [4 ]
Yee, Jerry [5 ]
Gillespie, Brenda [4 ]
Rolka, Deborah [6 ,7 ]
Saydah, Sharon [6 ,7 ]
Powe, Neil R. [1 ]
机构
[1] San Francisco Gen Hosp, Dept Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Family Hlth Care Nursing, San Francisco, CA 94143 USA
[3] Tufts Med Ctr, Dept Med, Boston, MA USA
[4] Univ Michigan, Dept Med, Ann Arbor, MI 48109 USA
[5] Henry Ford Hosp, Detroit, MI 48202 USA
[6] Ctr Dis Control & Prevent, Div Diabet Translat, Atlanta, GA USA
[7] Ctr Dis Control & Prevent, Div Diabet Translat, Hyattsville, MD USA
关键词
Chronic kidney disease; renal function; sleep duration; leg symptoms; sleep aids; CHRONIC KIDNEY-DISEASE; QUALITY-OF-LIFE; THRICE-WEEKLY HEMODIALYSIS; RESTLESS LEGS SYNDROME; SERUM CREATININE; MATCHED CONTROLS; APNEA; DISORDERS; PREVALENCE; OUTCOMES;
D O I
10.1053/j.ajkd.2011.05.024
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Sleep-related problems, which have been associated with poor health outcomes, have not been investigated thoroughly in people with chronic kidney disease (CKD). We examined the prevalence of a variety of sleep-related problems in persons with and without CKD. Study Design: National cross-sectional survey (National Health and Nutrition Examination Survey 2005-2008). Setting & Participants: Community-based survey of 9,110 noninstitutionalized US civilian residents 20 years or older. Predictor: CKD, defined as estimated glomerular filtration rate (eGFR) of 15-59 mL/min/1.73 m(2) (stages 3 and 4) or eGFR >= 60 mL/min/1.73 m(2) and albumin-creatinine ratio >= 30 mg/g (stages 1 and 2). Outcome: Sleep quality, defined using self-report in a multi-item sleep questionnaire including items from previously validated instruments. Measurements: Albuminuria and eGFR assessed from urine and blood samples; sleep, demographics, and comorbid conditions assessed using a standardized questionnaire. Results: Inadequate sleep (<= 6 hours per night) differed by CKD severity (37.4%, 43.0%, and 30.9% for no CKD, CKD stages 1 and 2, and CKD stages 3 and 4, respectively; P = 0.003). Frequent sleeping pill use (8.4%, 9.9%, and 16.6%), leg symptoms (39.2%, 48.0%, and 50.9%), and nocturia (20.9%, 35.2%, and 43.6%; P < 0.001 for all) also differed by CKD severity. After adjustment for age, sex, race/ethnicity, obesity, diabetes, and cardiovascular disease, the prevalence of these sleep-related problems remained higher in people with CKD stages 1 and 2 relative to no CKD. Most other measures of sleep quality, disorder, and functional outcomes did not differ by CKD. Limitations: Inability to establish causality and possible unmeasured confounding. Conclusion: Providers should be aware of early sleep-related CKD manifestations, including inadequate sleep, leg symptoms, and nocturia, and of the high rate of reported sleep medication use in this population. Am J Kidney Dis. 58(4): 554-564. (C) 2011 by the National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:554 / 564
页数:11
相关论文
共 44 条
  • [1] Sleep and its disorders in aging populations
    Ancoli-Israel, Sonia
    [J]. SLEEP MEDICINE, 2009, 10 : S7 - S11
  • [2] Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1175
  • [3] Restless legs syndrome in pediatric patients with chronic kidney disease
    Applebee, Garrick A.
    Guillot, Ann P.
    Schuman, Catherine C.
    Teddy, Sarah
    Attarian, Hrayr P.
    [J]. PEDIATRIC NEPHROLOGY, 2009, 24 (03) : 545 - 548
  • [4] Argekar Pushkar, 2007, Hemodial Int, V11, P435, DOI 10.1111/j.1542-4758.2007.00214.x
  • [5] Comparison of Sleep/Wake Behavior in CKD Stages 4 to 5 and Hemodialysis Populations Using Wrist Actigraphy
    Barmar, Babak
    Dang, Qianyu
    Isquith, Daniel
    Buysse, Daniel
    Unruh, Mark
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (04) : 665 - 672
  • [6] Beecroft JM, 2009, J CLIN SLEEP MED, V5, P115
  • [7] Centers for Disease Control and Prevention, About the National Health and Nutrition Examination Survey
  • [8] Centers for Disease Control and Prevention, AN REP GUID NAT HLTH
  • [9] Development of the FOSQ-10: A Short Version of the Functional Outcomes of Sleep Questionnaire
    Chasens, Eileen R.
    Ratcliffe, Sarah J.
    Weaver, Terri E.
    [J]. SLEEP, 2009, 32 (07) : 915 - 919
  • [10] Pain, sleep disturbance, and quality of life in patients with chronic kidney disease
    Cohen, Scott D.
    Patel, Samir S.
    Khetpal, Prashant
    Peterson, Rolf A.
    Kimmel, Paul L.
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 2 (05): : 919 - 925